Max Healthcare Institute Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Max Healthcare Q3 revenue rises to Rs. 2,608 Cr, registering growth of +10% YoY; Network Operating EBITDA grows to Rs. 648 Cr; PAT grows by +9% YoY to Rs. 344 Cr".
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Max Healthcare reported its Q3 FY26 results, with revenue rising to Rs. 2,608 crore, marking a 10% year-on-year growth. Network Operating EBITDA grew to Rs. 648 crore, indicating healthy operating performance. Profit After Tax (PAT) came in at Rs. 344 crore, up 9% YoY. The double-digit growth in both revenue and profit reflects steady operational momentum across the hospital network.
Positive for shareholders — consistent double-digit revenue and profit growth suggest strong business momentum, likely to be viewed favorably by the market. The improving EBITDA indicates better operating efficiency, which could support the stock's near-term sentiment.